Abstract
Selective inactivation of cytosolic thiolase by 2-alkynoyl-CoA via its intrinsic isomerase activity was studied, which provides an example for rationally developing mechanism-based inhibitors based on a side activity of the enzyme, and may become a supplemental method for better treatment of cardiovascular disease and cancer. © 2007 American Chemical Society.
| Original language | English |
|---|---|
| Pages (from-to) | 3877-3880 |
| Journal | Organic Letters |
| Volume | 9 |
| Issue number | 20 |
| DOIs | |
| Publication status | Published - 27 Sept 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Inactivation of thiolase by 2-alkynoyl-CoA via its intrinsic isomerase activity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver